When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...

1. Huang J. Disitamab vedotin plus tislelizumab as nephron-sparing therapy for high-risk upper tract urothelial carcinoma: The phase II DISTINCT-I trial. Presented at: ESMO 2025 Congress; October ...

Third quarter performance driven by strong portfolio royalty revenue growth of 47%2025 full year revenue guidance increased to $225 million - ...

In A Nutshell • A pig kidney with just one genetic modification functioned in a human for 61 days before being removed as ...

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...

The Liberation From Acute Dialysis (LIBERATE-D) randomized clinical trial tested the value of a conservative vs conventional hemodialysis strategy on recovery of kidney function in stable patients ...

These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification.

HOUSTON -- Two commonly used kidney function tests had a large degree of disagreement and were linked with serious health outcomes in patients with chronic kidney disease (CKD), according to a ...

Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose ...

Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining ...